معرفی
Paul Lorigan is a Professor of Medical Oncology at the University of Manchester and Honorary Consultant Medical Oncologist at the Christie NHS Foundation Trust. His research focuses on developing novel treatments for malignant melanoma, with significant contributions to international clinical trials and translational research.
- Key roles: Chair Elect of EORTC Melanoma Group, former Chair of Melanoma Focus
- Grants: Wellcome Senior Investigator Award (clinical/translational component), €6M/£4M immunotherapy grants, £213K national study
- Research areas: Melanoma clinical trials, immunotherapy, BRAF mutation-targeted therapies, microbiome interactions with immunotherapy, cancer prevention strategies
- Teaching: Co-supervises PhD students, lectures globally on melanoma, contributes to medical education via Medscape and ESMO Masterclass
His work has revolutionized advanced melanoma management through pivotal clinical trials and national guideline development. Recent publications emphasize adjuvant therapy optimization, microbiome dynamics in immunotherapy, and international clinical practice standards.
Scientific contributions include:
- International leadership in melanoma clinical trials
- Expert advisor to NICE and EORTC
- Chair of Christie Hospital Melanoma Disease Orientated Group (2002–present)
- Key architect of practice-changing melanoma research
Active in education through:
- Medscape content editor/presenter
- ESO-ESMO Masterclass lectures
- Editorial Board: Melanoma Matters
۰مقاله منتشرشده
